Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennon Regulatory News (PNN)

Share Price Information for Pennon (PNN)

Share Price is delayed by 15 minutes
Get Live Data
470.00    0.00 (0.00%)
Bid:
471.00
Ask:
471.40
Spread: 0.40 (0.085%)
Market Cap: £2.22b
PNN Live PriceLast checked at - London Stock Exchange

Intraday Pennon Share Chart

PR19 Draft Determination for South West Water

11 Apr 2019 07:00

RNS Number : 8311V
Pennon Group PLC
11 April 2019
 

PENNON GROUP PLC

11 April 2019

Draft Determination for South West Water

Following the announcement on 31 January that the 2020-2025 business plan of Pennon Group's subsidiary, South West Water Limited, was assessed as 'fast tracked', Ofwat has today published a Draft Determination for South West Water which is largely based on the company's own business plan and forecasts. 

South West Water is the only water and sewerage company to have achieved fast track status for two consecutive price reviews.

South West Water is now reviewing the Draft Determination proposed by Ofwat and will respond to the Regulator by the due date of 24 May 2019. Ofwat will announce its Final Determination for the company on 11 December 2019.

The company's five-year business plan was submitted to Ofwat in September 2018 following its biggest ever consultation, which showed a customer approval rating of 88% and received the support of the independent WaterFuture Customer Panel.

For further information, please contact:

 

Pennon

Susan Davy

Sarah Heald

Jennifer Cooke

01392 443 168

 

 

Chief Financial Officer 

Director of Corporate Affairs and Investor Relations

Investor Relations Officer 

Finsbury

Harry WorthingtonFaeth Birch

0207 251 3801

 

Cautionary statement in respect of forward-looking statements

Certain statements in this announcement are forward-looking statements relating to the Group's operations, performance and financial position based on current expectations of, and assumptions and forecasts made by, management. They are subject to a number of risks, uncertainties and other factors that could cause actual results, performance or achievements of the Group to differ materially from any outcomes or results expressed or implied by such forward-looking statements. The Group's principal risks were described in the 2018 Pennon Group Annual Report which can be viewed online at http://annualreport.pennon-group.co.uk/. Such forward looking statements should therefore be construed in light of such risks, uncertainties and other factors and undue reliance should not be placed on them. They are made only as of the date of this announcement and no representation, assurance, guarantee or warranty is given in relation to them including as to their accuracy, completeness, or the basis on which they are made. No obligation is accepted to publicly revise or update these forward-looking statements or adjust them as a result of new information or for future events or developments, except to the extent legally required. Nothing in this Statement should be construed as a profit forecast.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUROWRKVASAAR
Date   Source Headline
8th Jul 20263:26 pmRNSEMTN: Publication of Supplementary Prospectus
8th Jul 202611:43 amRNSResult of AGM
8th Jul 20267:00 amRNSEMTN Programme: Publication of Final Terms
1st Jul 20267:00 amRNSTotal Voting Rights
22nd Jun 202610:55 amRNSDirector/PDMR Shareholding
18th Jun 20262:53 pmRNSEMTN: Publication of Supplementary Prospectus
16th Jun 20267:00 amRNSPublication of Annual Report and Accounts 2026
10th Jun 20267:00 amRNSFull Year Results 2025/26
1st Jun 20267:00 amRNSTotal Voting Rights
29th May 20262:06 pmRNSHolding(s) in Company
20th May 20261:48 pmRNSDirector/PDMR Shareholding
14th May 202612:03 pmRNSDirector/PDMR Shareholding
6th May 20262:12 pmRNSAdmission to Trading
1st May 20264:31 pmRNSHolding(s) in Company
1st May 20267:00 amRNSTotal Voting Rights
30th Apr 20263:11 pmRNSHolding(s) in Company
27th Apr 20264:34 pmRNSHolding(s) in Company
24th Apr 20263:29 pmRNSHolding(s) in Company
22nd Apr 20264:30 pmRNSHolding(s) in Company
21st Apr 20261:17 pmRNSDirector/PDMR Shareholding
20th Apr 20264:09 pmRNSHolding(s) in Company
14th Apr 20264:24 pmRNSRescheduled Full-Year Results Date
1st Apr 20267:00 amRNSTotal Voting Rights
20th Mar 20262:06 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTrading Statement
2nd Mar 20267:00 amRNSTotal Voting Rights
23rd Feb 202612:58 pmRNSDirector/PDMR Shareholding
10th Feb 20267:00 amRNSConfirmation of Chief Executive Officer Start Date
5th Feb 202610:58 amRNSHolding(s) in Company
2nd Feb 20267:01 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSBlock listing Interim Review
23rd Jan 20263:21 pmRNSDirector/PDMR Shareholding
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
23rd Dec 20253:29 pmRNSDirector/PDMR Shareholding
23rd Dec 20253:29 pmRNSDirector/PDMR Shareholding
11th Dec 20251:16 pmRNSConfirmed Financial Calendar
9th Dec 20254:01 pmRNSDirector/PDMR Shareholding
9th Dec 20257:00 amRNSPennon Group CEO Transition Arrangements
1st Dec 20253:42 pmRNSEMTN: Publication of Supplementary Prospectus
1st Dec 20257:00 amRNSTotal Voting Rights
27th Nov 20257:00 amRNSHalf Year Results 2025/26
21st Nov 20254:24 pmRNSDirector/PDMR Shareholding
3rd Nov 20257:00 amRNSTotal Voting Rights
22nd Oct 20251:26 pmRNSDirector/PDMR Shareholding
7th Oct 20257:00 amRNSPennon appoints new Non-Executive Director
3rd Oct 20252:19 pmRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSPennon Group appoints Keith Haslett as new CEO
1st Oct 20257:00 amRNSTotal Voting Rights
26th Sep 20257:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.